Folkman, J. (2003). Fundamental concepts of the angiogenic process. Curr Mol Med 3, 643-651.Folkman, J., and Kalluri, R. (2004). <strong>Cancer</strong> without disease. Nature 427, 787.Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M.(1995). 15-Deoxy-<strong>de</strong>lta 12, 14-prostag<strong>la</strong>ndin J2 is a ligand for the adipocyte d<strong>et</strong>erminationfactor PPAR gamma. Cell 83, 803-812.Frayn, K. N., Karpe, F., Fielding, B. A., Macdonald, I. A., and Coppack, S. W. (2003).Integrative physiology of human adipose tissue. Int J Obes Re<strong>la</strong>t M<strong>et</strong>ab Disord 27, 875-888.Fukao, T., Lopaschuk, G. D., and Mitchell, G. A. (2004). Pathways and control of k<strong>et</strong>onebody m<strong>et</strong>abolism: on the fringe of lipid biochemistry. Prostag<strong>la</strong>ndins Leukot Essent FattyAcids 70, 243-251.Funicello, M., Novelli, M., Ragni, M., Vottari, T., Cocuzza, C., Soriano-Lopez, J., Chiellini,C., Boschi, F., Marzo<strong>la</strong>, P., Masiello, P., <strong>et</strong> al. (2007). Cathepsin K null mice show re<strong>du</strong>cedadiposity <strong>du</strong>ring the rapid accumu<strong>la</strong>tion of fat stores. PLoS One 2, e683.Fusek, M., Mares, M., Vagner, J., Voburka, Z., and Baudys, M. (1991). Inhibition of asparticproteinases by propart pepti<strong>de</strong>s of human procathepsin D and chicken pepsinogen. FEBS L<strong>et</strong>t287, 160-162.Fusek, M., and V<strong>et</strong>vicka, V. (1994). Mitogenic function of human procathepsin D: the role ofthe propepti<strong>de</strong>. Biochem J 303 ( Pt 3), 775-780.Fusek, M., and V<strong>et</strong>vicka, V. (2005). Dual role of cathepsin D: ligand and protease. BiomedPap Med Fac Univ Pa<strong>la</strong>cky Olomouc Czech Repub 149, 43-50.Garcia, M., Derocq, D., Pujol, P., and Rochefort, H. (1990). Overexpression of transfectedcathepsin D in transformed cells increases their malignant phenotype and m<strong>et</strong>astatic potency.Oncogene 5, 1809-1814.Garg, A., and Aggarwal, B. B. (2002). Nuclear transcription factor-kappaB as a targ<strong>et</strong> forcancer drug <strong>de</strong>velopment. Leukemia 16, 1053-1068.Glon<strong>du</strong>, M., Coopman, P., Laurent-Matha, V., Garcia, M., Rochefort, H., and Liaud<strong>et</strong>-Coopman, E. (2001). A mutated cathepsin-D <strong>de</strong>void of its catalytic activity stimu<strong>la</strong>tes thegrowth of cancer cells. Oncogene 20, 6920-6929.Glon<strong>du</strong>, M., Liaud<strong>et</strong>-Coopman, E., Derocq, D., P<strong>la</strong>t<strong>et</strong>, N., Rochefort, H., and Garcia, M.(2002). Down-regu<strong>la</strong>tion of cathepsin-D expression by antisense gene transfer inhibits tumorgrowth and experimental lung m<strong>et</strong>astasis of human breast cancer cells. Oncogene 21, 5127-5134.82
Gonzalez-Ve<strong>la</strong>, M. C., Garijo, M. F., Fernan<strong>de</strong>z, F., Buelta, L., and Val-Bernal, J. F. (1999).Cathepsin D in host stromal cells is associated with more highly vascu<strong>la</strong>r and aggressiveinvasive breast carcinoma. Histopathology 34, 35-42.Gopa<strong>la</strong>krishnan, M. M., Grosch, H. W., Locatelli-Hoops, S., Werth, N., Smolenova, E.,N<strong>et</strong>tersheim, M., Sandhoff, K., and Hasilik, A. (2004). Purified recombinant humanprosaposin forms oligomers that bind procathepsin D and affect its autoactivation. Biochem J383, 507-515.Goudriaan, J. R., Tacken, P. J., Dahlmans, V. E., Gijbels, M. J., van Dijk, K. W., Havekes, L.M., and Jong, M. C. (2001). Protection from obesity in mice <strong>la</strong>cking the VLDL receptor.Arterioscler Thromb Vasc Biol 21, 1488-1493.Gregoire, F. M., Smas, C. M., and Sul, H. S. (1998). Un<strong>de</strong>rstanding adipocyte differentiation.Physiol Rev 78, 783-809.Griffiths, J. R. (1991). Are cancer cells acidic? Br J <strong>Cancer</strong> 64, 425-427.Haidar, B., Kiss, R. S., Sarov-B<strong>la</strong>t, L., Brun<strong>et</strong>, R., Har<strong>de</strong>r, C., McPherson, R., and Marcel, Y.L. (2006). Cathepsin D, a lysosomal protease, regu<strong>la</strong>tes ABCA1-mediated lipid efflux. J BiolChem 281, 39971-39981.Han, J., Luo, T., Gu, Y., Li, G., Jia, W., and Luo, M. (2009a). Cathepsin K regu<strong>la</strong>tesadipocyte differentiation: possible involvement of type I col<strong>la</strong>gen <strong>de</strong>gradation. Endocr J 56,55-63.Han, S. H., Sakuma, I., Shin, E. K., and Koh, K. K. (2009b). Antiatherosclerotic and antiinsulinresistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis 52,126-140.Haque, A., Banik, N. L., and Ray, S. K. (2008). New insights into the roles of endolysosomalcathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potentialtherapeutics. CNS Neurol Disord Drug Targ<strong>et</strong>s 7, 270-277.Herz, J., Clouthier, D. E., and Hammer, R. E. (1992). LDL receptor-re<strong>la</strong>ted proteininternalizes and <strong>de</strong>gra<strong>de</strong>s uPA-PAI-1 complexes and is essential for embryo imp<strong>la</strong>ntation.Cell 71, 411-421.Heylen, N., Vincent, L. M., Devos, V., Dubois, V., Remacle, C., and Trou<strong>et</strong>, A. (2002).Fibrob<strong>la</strong>sts capture cathepsin D secr<strong>et</strong>ed by breast cancer cells: possible role in the regu<strong>la</strong>tionof the invasive process. Int J Oncol 20, 761-767.Hilfiker-Kleiner, D., Kaminski, K., Po<strong>de</strong>wski, E., Bonda, T., Schaefer, A., Sliwa, K., Forster,O., Quint, A., Landmesser, U., Doerries, C., <strong>et</strong> al. (2007). A cathepsin D-cleaved 16 kDa formof pro<strong>la</strong>ctin mediates postpartum cardiomyopathy. Cell 128, 589-600.83
- Page 1 and 2:
Université Montpellier I UFR Méd
- Page 3 and 4:
Un grand merci à tous mes collabor
- Page 5 and 6:
TitleBreast cancer and tumoral micr
- Page 7 and 8:
Cancer du sein et micro-environneme
- Page 9 and 10:
C. PRESENTATION DU TRAVAIL DE THESE
- Page 11 and 12:
But de la thèseLa cathepsine-D (ca
- Page 13 and 14:
I. Le tissu adipeux1) Généralité
- Page 15 and 16:
(Adenosine triphosphate). Cette pro
- Page 18 and 19:
Cette synthèse de novo a lieu dans
- Page 20 and 21:
ABFigure 6 : Schéma de la oxydati
- Page 22 and 23:
d. Ladipocyte : une cellule sécré
- Page 24 and 25:
3) Ladipogenèsea. Les différentes
- Page 26 and 27:
. Les facteurs de transcriptionLa d
- Page 28 and 29:
Lexpression de C/EBP est quant à e
- Page 30 and 31:
adipeux. Les analyses histologiques
- Page 32 and 33:
adipocyteFigure 10 : Schéma repré
- Page 34 and 35:
II. La cathepsine-D1) Synthèse, ma
- Page 36 and 37:
les cath-B et L, en une forme matur
- Page 38 and 39:
Il existe deux RM6P : le RM6P/IGFII
- Page 40 and 41:
2) Fonctions de la cath-Da. Dans la
- Page 42 and 43:
. Dans les pathologiesEn plus de se
- Page 44 and 45:
c. Rôles et mécanismes daction da
- Page 46 and 47:
carcinome de prostate serait respon
- Page 48 and 49:
La cath-D joue donc un rôle import
- Page 50 and 51:
Une fois le marquage des peptides e
- Page 52 and 53:
Afin de réaliser ce projet, nous a
- Page 54 and 55:
III. Le récepteur LRP11) Organisat
- Page 56 and 57:
2) Trafic intra-cellulaireComme le
- Page 58 and 59:
LRP1αLRP1Membrane associatedprotea
- Page 60 and 61:
Tableau 3 : Ligands connus du LRP1(
- Page 62 and 63:
I. Etude du rôle de la cathepsine
- Page 64 and 65:
Cathepsin-D, a key protease in brea
- Page 66 and 67:
IntroductionConsumption of meals ri
- Page 68 and 69:
(Fig. 1A, panel a). This differenti
- Page 70 and 71:
differentiated adipocyte (Fig. 4B).
- Page 72 and 73: DiscussionOur results demonstrate t
- Page 74 and 75: from normal and peri-al breast adip
- Page 76 and 77: mouse RS9 (sens 5CGGCCCGGGAGCTGTTGA
- Page 78 and 79: agreement of local ethic committee.
- Page 80 and 81: Statistical analysis. Results are e
- Page 82 and 83: Loncarek J, Freiss G, Vignon F and
- Page 84 and 85: Aa3000 *b4000*B8000**cath-D mRNA(ar
- Page 86 and 87: ABcath-D mRNA(ratio RS9)PPARg mRNA(
- Page 88 and 89: A D3 D7 D14D0BaD0 D3 D7 D14D0 D3 D7
- Page 90 and 91: AshLucshcath-DF442A C34 C37 A4 D10c
- Page 92 and 93: AF442-AC34C37A4D10BF442-AC34C37A4D1
- Page 94 and 95: II. Etude du rôle du LRP1 dans les
- Page 96 and 97: 2) Article 2:LRP1 receptor controls
- Page 98 and 99: LRP1, Adipogenesis, Obesityrelative
- Page 100 and 101: LRP1, Adipogenesis, ObesityFigure 3
- Page 102 and 103: LRP1, Adipogenesis, ObesityFigure 5
- Page 104 and 105: LRP1, Adipogenesis, ObesitySome ins
- Page 106 and 107: LRP1, Adipogenesis, ObesityLipolysi
- Page 108 and 109: CONCLUSIONLa cathepsine D (cath-D)
- Page 110 and 111: la souris obèses. Enfin, linhibiti
- Page 112 and 113: carcinogénique sont encore mal con
- Page 114 and 115: Ce travail de thèse a étudié, po
- Page 116 and 117: REFERENCESAhima, R. S. (2006). Adip
- Page 118 and 119: implicates them as antigen presenti
- Page 120 and 121: Cataldo, A. M., Barnett, J. L., Ber
- Page 124 and 125: Hofmann, S. M., Zhou, L., Perez-Til
- Page 126 and 127: Langin, D. (2006a). Adipose tissue
- Page 128 and 129: Ludwig, T., Ovitt, C. E., Bauer, U.
- Page 130 and 131: Nirde, P., Derocq, D., Maynadier, M
- Page 132 and 133: Rozanov, D. V., Hahn-Dantona, E., S
- Page 134 and 135: Taleb, S., Cancello, R., Clement, K
- Page 136 and 137: Xiao, Y., Junfeng, H., Tianhong, L.
- Page 138 and 139: F. ANNEXE98
- Page 140 and 141: Cathepsin D is a new ligand for ext
- Page 142 and 143: INTRODUCTIONLysosomal aspartic prot
- Page 144 and 145: pcDNA3.1(+)Myc-tagged LRP1b into pc
- Page 146 and 147: (Protein refolding kit, Novagen) fo
- Page 148 and 149: anti-mouse-gold (Aurion). Sections
- Page 150 and 151: not secrete detectable levels of pr
- Page 152 and 153: using cath-D-/- MEF transfected wit
- Page 154 and 155: co-culture outgrowth assays with ca
- Page 156 and 157: REFERENCES1. Vignon, F., Capony, F.
- Page 158 and 159: steps in vivo: proliferation, angio
- Page 160 and 161: 28. Laurent-Matha, V., Lucas, A., H
- Page 162 and 163: 42. Zurhove, K., Nakajima, C., Herz
- Page 164 and 165: Figure 1. Cath-D interacts with the
- Page 166 and 167: Figure 2. Cath-D binds to residues
- Page 168 and 169: Figure 3. Cath-D interacts with LRP
- Page 170 and 171: Figure 5. Silencing LRP1 in cath-D
- Page 172 and 173:
Figure 1. Cath-D interacts with the
- Page 174 and 175:
Figure 6. LRP1 is the receptor medi
- Page 176 and 177:
Beaujouin, Figure Sup. 2cath-D-/-ME
- Page 178:
RésuméLaspartyl protéase catheps